• Research
  • About
  • Experts
Carnegie India logoCarnegie lettermark logo
Technology
{
  "authors": [
    "Dan Baer"
  ],
  "type": "legacyinthemedia",
  "centerAffiliationAll": "",
  "centers": [
    "Carnegie Endowment for International Peace"
  ],
  "collections": [
    "Coronavirus"
  ],
  "englishNewsletterAll": "",
  "nonEnglishNewsletterAll": "",
  "primaryCenter": "Carnegie Endowment for International Peace",
  "programAffiliation": "",
  "programs": [],
  "projects": [],
  "regions": [
    "North America",
    "United States"
  ],
  "topics": [
    "Foreign Policy",
    "Global Governance"
  ]
}

Source: Getty

In The Media

The Virus Has Exposed the Recklessness of Trump’s “America First”

Washington’s failure to lead in a moment of global crisis will have lasting effects on its stature in the world.

Link Copied
By Dan Baer
Published on Mar 18, 2020

Source: Foreign Policy

Last weekend, the German newspaper Die Welt reported that the administration of U.S. President Donald Trump had sought to entice a German company working on a coronavirus vaccine to move its research operations from Europe to the United States. According to an unnamed German official quoted by the Berlin-based paper, the Trump administration’s intent was to have the eventual vaccine “only for America.”

It’s still unclear what exactly happened. Was there an attempt to buy the company? With private money or public funds? Trump’s new acting director of national intelligence who remains ambassador to Germany, Richard Grenell, denied the report. Jens Spahn, the German health minister, confirmed it. It seems likely that there was some sort of overture—even if it is also likely that we don’t have all the facts. As former ambassador Steven Pifer observed on Twitter, while there once was a time when a story like this—the United States sneaking around the back of a close ally to steal medicine—would have seemed unthinkable, the past behavior of the Trump administration makes it seem entirely plausible.

The story is now out there, and there has been no small amount of hand-wringing over the damage that has surely been done to the image of the United States and the U.S.-German relationship: Imagine the reaction of the German people, who are dutifully following Chancellor Angela Merkel’s request to self-isolate in order to flatten the coronavirus curve, as they read that the U.S. president was trying to buy critical medical research with the hopes of using it only for his own country. Add this to the fact that in Italy, it is China, not the United States, that is delivering medical equipment and assistance as the Italian health system bends under the strain of the pandemic. And furthermore, that Trump last week announced restrictions on travelers to the United States from Europe without prior coordination with European partners or even a word of warning. Suffice it to say that the past week has marked a relative low point in trans-Atlantic relations.

The past week also underscores two consistent failings of Trump’s foreign policy: First, that the Trump administration is lousy at preserving the trust and goodwill that is essential to sustained, cooperative relationships with other governments. And second, that the coronavirus pandemic is laying clear the folly of Trump’s “America First” theory of foreign policy—and of other approaches to foreign policy, on both the left and the right, that are premised on the fiction that the welfare and interests of the United States can be protected and defended separately and apart from the welfare of the world.

What’s so disheartening about the idea that Trump might try to poach a vaccine for exclusive use in the United States is not the craven greediness of it; it’s that it so obviously misunderstands the nature of the threat this pandemic poses. Countries need to cooperate internationally to ensure that somewhere in the world—anywhere in the world—a vaccine is discovered as quickly as possible, and ultimately we need a vaccine to be globally accessible. It is plain stupid to think that hoarding medical research that could yield interventions that would treat or protect against a pandemic would actually serve U.S. interests.

The United States needs a functioning European economy. American farmers and businesses depend on trade with the rest of the world. U.S.-based multinationals depend on foreign workforces. Pandemics can cause instability and conflict that endanger American troops and interests overseas. The United States is a global power: The world depends on the United States, and the United States depends on the world.

The response to the coronavirus might have been more efficient if it had first appeared in a country that wasn’t authoritarian and didn’t suppress news about the virus in the early weeks. And it might have been more effective if the United States were helping to lead and coordinate the world’s response to the outbreak, rather than claiming for weeks that the virus was not going to affect it and therefore was nothing to be concerned about, before pursuing a set of policies that surprised the closest U.S. allies.

When I was in government, I often wanted to tell people that they couldn’t use the words “Marshall Plan” in meetings: It seemed like every meeting about a crisis somewhere in the world had one person who would say, “What we need is a Marshall Plan for [insert country or region].”  And while that trope became frustratingly predictable, it of course reflected the fact that moments of great need can be moments of great opportunity for American leadership. For a generation or more, the Marshall Plan’s intent and effects had a lasting impact on the popularity of and trust in the United States across Europe. Trump’s mismanagement of the domestic coronavirus response has been dire. America’s failure to lead in a moment of global crisis will have lasting effects on its stature in the world.

This article was originally published in Foreign Policy.

Dan Baer
Senior Vice President for Policy Research, Director, Europe Program
Dan Baer
Foreign PolicyGlobal GovernanceNorth AmericaUnited States

Carnegie India does not take institutional positions on public policy issues; the views represented herein are those of the author(s) and do not necessarily reflect the views of Carnegie, its staff, or its trustees.

More Work from Carnegie India

  • Commentary
    The Impact of U.S. Sanctions and Tariffs on India’s Russian Oil Imports

    This piece examines India’s response to U.S. sanctions and tariffs, specifically assessing the immediate market consequences, such as alterations in import costs, and the broader strategic implications for India’s energy security and foreign policy orientation.

      Vrinda Sahai

  • Commentary
    NISAR Soars While India-U.S. Tariff Tensions Simmer

    On July 30, 2025, the United States announced 25 percent tariffs on Indian goods. While diplomatic tensions simmered on the trade front, a cosmic calm prevailed at the Sriharikota launch range. Officials from NASA and ISRO were preparing to launch an engineering marvel into space—the NASA-ISRO Synthetic Aperture Radar (NISAR), marking a significant milestone in the India-U.S. bilateral partnership.

      Tejas Bharadwaj

  • Commentary
    TRUST and Tariffs

    The India-U.S. relationship currently appears buffeted between three “Ts”—TRUST, Tariffs, and Trump.

      Arun K. Singh

  • Commentary
    Indian Airstrikes in Pakistan: May 7, 2025

    On May 7, 2025, between 1:05 and 1:30 a.m. (IST), airstrikes carried out by the Indian Air Force hit nine locations inside Pakistan and Pakistan occupied Kashmir (PoK). It was codenamed Operation Sindoor.

      Rudra Chaudhuri

  • Research
    Views From Taipei: Essays by Young Indian Scholars on China

    This compendium brings together three essays by scholars who participated in Carnegie India's Security Studies Dialogue in 2024, each examining a different aspect of China’s policies. Drawing on their expertise and research, the authors offer fresh perspectives on key geopolitical challenges.

      • +1

      Vijay Gokhale, Suyash Desai, Amit Kumar, …

Get more news and analysis from
Carnegie India
Carnegie India logo, white
Unit C-4, 5, 6, EdenparkShaheed Jeet Singh MargNew Delhi – 110016, IndiaPhone: 011-40078687
  • Research
  • About
  • Experts
  • Projects
  • Events
  • Contact
  • Careers
  • Privacy
  • For Media
Get more news and analysis from
Carnegie India
© 2026 Carnegie Endowment for International Peace. All rights reserved.